Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
142280
vs
K
KOSPI 200
Over the past 12 months, Green Cross Medical Science Corp has underperformed KOSPI 200, delivering a return of -30% compared to KOSPI 200's +40% growth.
Stocks Performance
142280 vs KOSPI 200
Performance Gap
142280 vs KOSPI 200
Performance By Year
142280 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Green Cross Medical Science Corp
Glance View
Green Cross Medical Science Corp is a South Korean healthcare company that makes vaccines, blood-derived medicines, and diagnostic products. Its products help prevent infectious disease, treat conditions that need plasma-based therapies, and support medical testing in hospitals and labs. In simple terms, it sits in the part of the healthcare chain that turns biological materials into finished medicines and test kits. The company sells mainly to hospitals, clinics, public health buyers, and other medical distributors. It also serves pharmaceutical partners through manufacturing and supply relationships. Green Cross Medical Science makes money by selling these finished drugs and diagnostics, and in some cases by producing products for other healthcare firms under contract. What makes the business model different is that it depends on specialized biology, strict quality control, and regulatory approval rather than ordinary factory production. That gives the company a role similar to a specialty supplier: it is not a broad consumer healthcare brand, but a maker of essential medical products that are tied closely to disease prevention, treatment, and clinical testing.